Found 26 matching trials
Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes
N/AThe primary objective of the study is to evaluate the effectiveness of prop...
Impact on French Physician's Haemophilia Treatment Management Decision Based on Systematic Joint Examination
NAThis low interventional study aims to describe if and how the haemophilia t...
Location
Swedish Orphan Biovitrum Research site
Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
PHASE4The purpose of this study is to determine the immunologic and overall safet...
Location
Oddzial Chorob Wewnetrznych i Hematologii
Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A
PHASE3A prospective, non-controlled, international, multi-centre phase 3 study to...
Location
Kirov SSC Hematology and Transfusiology
A Study With OPTIVATE® in People With Von Willebrand Disease
PHASE3The main objective of the study is to assess the pharmacokinetics of OPTIVA...
Location
Rambam Health Care Campus, 8 Haaliya St., Bat-Galim
Type 3 Von Willebrand International Registries Inhibitor Prospective Study
N/AInternational Registries and Prospective Study on Type 3 Von Willebrand's D...
Location
Helsinki University Central Hospital, Department Internal Medicine, Coagulation Disorders, at Haematology and Laboratory Services
A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD
PHASE3The EMPOWER trial is a pilot multi-center, placebo-controlled (normal salin...
Location
St. Michael's Hospital
Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development
PHASE3This is a clinical study to investigate how well Biostate works in treatmen...
Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate
N/AVon Willebrand disease (VWD) is the most common inherited bleeding disorder...
Location
Assiut university
Alphanate in Immune Tolerance Induction Therapy
PHASE2This is a multicenter, multinational, prospective, single-arm, nonrandomize...